RSMDF Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 апр. 2024 @ 16:48):

Stats
Объем за сегодня	260 000
Средний объем	1.00
Рыночная капитализация	31.67B
EPS	$0.149 ( 2023-09-29 )
Дата следующего отчета о доходах	( $0.0800 ) 2024-08-01
Last Dividend	$0.0480 ( 2023-08-16 )
Next Dividend	$0 ( N/A )
P/E	27.23
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Douglas Robert Andrew	Buy	0
2023-11-27	Sandercock Brett	Sell	3 000	ResMed Common Stock
2023-11-22	Rider Michael J	Sell	72	ResMed Common Stock
2023-11-16	Burt Carol	Buy	1 768	ResMed Common Stock
2023-11-16	Farrell Michael J.	Buy	3 462	ResMed Common Stock

INSIDER POWER
17.77
Last 97 transactions
Buy: 212 786 \| Sell: 177 067

ResMed Inc. Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

ResMed Inc. Финансовые показатели

Annual	2023
Выручка:	$4.22B
Валовая прибыль:	$2.36B (55.78 %)
EPS:	$0.610

FY	2023
Выручка:	$4.22B
Валовая прибыль:	$2.36B (55.78 %)
EPS:	$0.610

FY	2022
Выручка:	$3.58B
Валовая прибыль:	$2.02B (56.57 %)
EPS:	$0.510

FY	2021
Выручка:	$3.20B
Валовая прибыль:	$1.84B (57.53 %)
EPS:	$0.327

Financial Reports:

No articles found.

ResMed Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0440 (N/A)	$0.0440 (N/A)	$0.0440 (N/A)	$0.0440 (N/A)	$0.0480 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

ResMed Inc. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.29 - Stable (25.84%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.170	2013-05-17
Last Dividend	$0.0480	2023-08-16
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	$1.168	--
Avg. Dividend % Per Year	0.00%	--
Score	4.33	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.29
Div. Directional Score	8.49	--

Next Divdend (Est)
(2024-05-06)

$0.0516 Estimate 19.76 %

Dividend Stability

0.53 Average

Dividend Score

4.33

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
YITYY	Ex Dividend Junior	2023-10-02	Annually	0.00%
MHGVY	Ex Dividend Knight	2023-09-01	Quarterly	0.00%
CNAF	Ex Dividend Knight	2023-08-24	Quarterly	0.00%
SSEZY	Ex Dividend Knight	2023-07-27	Semi-Annually	0.00%
HFBK	Ex Dividend Knight	2023-08-24	Quarterly	0.00%
AMNF	Ex Dividend Knight	2023-07-06	Quarterly	0.00%
NXGPY	Ex Dividend Knight	2023-07-06	Semi-Annually	0.00%
CWBK	Ex Dividend Junior	2023-09-14	Quarterly	0.00%
TMSNY	Ex Dividend Junior	2023-05-05	Annually	0.00%
IKTSY	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.216	1.500	5.67	8.51	[0 - 0.5]
returnOnAssetsTTM	0.141	1.200	5.31	6.37	[0 - 0.3]
returnOnEquityTTM	0.219	1.500	8.68	10.00	[0.1 - 1]
payoutRatioTTM	0.288	-1.000	7.12	-7.12	[0 - 1]
currentRatioTTM	3.04	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.393	0.800	6.51	5.21	[0.8 - 2.5]
cashRatioTTM	0.308	1.500	9.40	10.00	[0.2 - 2]
debtRatioTTM	0.151	-1.500	7.48	-10.00	[0 - 0.6]
interestCoverageTTM	-22.13	1.000	-9.31	-9.31	[3 - 30]
operatingCashFlowPerShareTTM	0.806	2.00	9.73	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.721	2.00	9.64	10.00	[0 - 20]
debtEquityRatioTTM	0.223	-1.500	9.11	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.574	1.000	3.77	3.77	[0.2 - 0.8]
operatingProfitMarginTTM	0.273	1.000	6.53	6.53	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.150	1.000	4.72	4.72	[0.2 - 2]
assetTurnoverTTM	0.650	0.800	9.00	7.20	[0.5 - 2]
Total Score				10.68

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.14	1.000	7.36	0	[1 - 100]
returnOnEquityTTM	0.219	2.50	9.15	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
dividendYielPercentageTTM	1.062	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.806	2.00	9.73	10.00	[0 - 30]
payoutRatioTTM	0.288	1.500	7.12	-7.12	[0 - 1]
pegRatioTTM	0.475	1.500	-0.167	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.268	1.000	5.81	0	[0.1 - 0.5]
Total Score				6.29

ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.